Answer
It is unknown whether voretigene neparvovec passes into human milk, Luxturna has not been studied in breast-feeding women, and a risk to newborns or infants cannot be excluded.
Sources for this answer
- Luxturna concentrate and solvent for solution for injectionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 9Document updated
Sources checked